Maternal sepsis and other maternal infections

Trials started per year, stacked by phase (darker = later phase). Source: ClinicalTrials.gov via Clin2, which tracks studies recruiting in recent years — early years undercount.

Maternal sepsis is curable or preventable in most cases. When antibiotics, source control, and supportive care are given quickly, infections can be stopped. In many regions, deaths have been falling for years, thanks to cleaner delivery practices and wider use of prophylactic antibiotics. The change is real, but it is not automatic: every improvement depends on health systems recognizing danger signs fast and acting before organ failure begins. There is no one landmark breakthrough to name; the hard-won gains come from consistently applying what already works. Research continues—six trials are now active, though none are in late-stage testing—so near-term treatment shifts are unlikely. The steady trend is toward fewer deaths, but access to emergency obstetric care remains the deciding factor. Closing that gap is the central challenge ahead.

Is maternal sepsis curable?

Yes. With timely antibiotics, source control, and supportive care, most infections can be cured. Early treatment greatly improves survival, though it depends on prompt recognition and available emergency care.

Are deaths from maternal sepsis decreasing?

In many regions, deaths have been falling over the past years due to improved hygiene, sterile delivery practices, and prophylactic antibiotics. However, reliable global data are incomplete, so the trend is not uniform everywhere.

Why do some women still die from it?

Because timely, high-quality care is not available everywhere. Delays in recognizing warning signs or reaching an emergency obstetric facility can turn a curable infection into a fatal one.

Are there new treatments being developed?

There are six active clinical trials, but none have reached phase 3. This means no major new therapy is likely in the immediate future. Current treatment remains antibiotics, source control, and supportive care.

What is the most important factor in survival?

Early recognition and rapid treatment. For every hour that antibiotics and source control are delayed, the risk of organ failure rises. Access to basic and emergency obstetric care is therefore decisive.